KUALA LUMPUR: CCM Duopharma Biotech Bhd has bought a 5.8% stake in South Korea’s SCM Lifescience Co, Ltd, which specialises in stem cell therapeutics, for RM20.24mil.
CCM Duopharma, which develops generic drugs and branded healthcare products, said this marked its foray into regenerative medicine.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!